The global interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5 percent, reports MarketsandMarkets. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices.
The angioplasty stents segment is estimated to account for the largest share of the global market in 2017 owing to the widespread use of stents. The thrombectomy devices segment is estimated to account for the largest share of the global plaque modification devices market. The large share of this segment can be attributed to the increasing demand for plaque removal procedures and rising incidences of plaque deposition. The guidewires segment is estimated to account for the largest share of the global other interventional cardiology devices market attributing to the growth in the number of interventional procedures and increasing use of guidewires in stenting procedures.
The global interventional cardiology devices market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the years to come. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia-Pacific countries and government support are driving the growth of the interventional cardiology devices market in this region.